Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.usj.es/handle/123456789/1026
Título : | Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed with Long COVID-19: Protocol for a Co-Creation Study of a Health Asset and an Analysis of Its Effectiveness and Cost-Effectiveness |
Autor: | Samper Pardo, Mario
León-Herrera, Sandra Oliván-Blázquez, Bárbara Benede-Azagra, Belen Magallón, Rosa Gómez-Soria, Isabel Calatayud Sanz, Estela Aguilar-Latorre, Alejandra Méndez-López, Fátima Pérez-Palomares, Sara Cobos-Rincon, Ana Valero Errazu, Diana Sagarra-Romero, Lucía Sanchez-Recio, Raquel |
Palabras clave : | Long COVID-19; APP; Health asset; Co-creation; Effectiveness; Cost-efficiency; Primary health care |
Fecha de publicación: | 27-dic-2023 |
Editorial : | MDPI |
Citación : | Samper-Pardo, M.; León-Herrera, S.; Oliván-Blázquez, B.; Benedé-Azagra, B.; Magallón-Botaya, R.; Gómez-Soria, I.; Calatayud, E.; Aguilar-Latorre, A.; Méndez-López, F.; Pérez-Palomares, S.; et al. Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed with Long COVID-19: Protocol for a Co-Creation Study of a Health Asset and an Analysis of Its Effectiveness and Cost-Effectiveness. Int. J. Environ. Res. Public Health 2023, 20, 462. https://doi.org/10.3390/ ijerph20010462 |
Resumen : | Objective: To analyse the overall effectiveness and cost-efficiency of a mobile application (APP) as a community health asset (HA) with recommendations and recovery exercises created bearing in mind the main symptoms presented by patients in order to improve their quality of life, as well as other secondary variables, such as the number and severity of ongoing symptoms, physical and cognitive functions, affective state, and sleep quality. Methods: The first step was to design and develop the technologic community resource, the APP, following the steps involved in the process of recommending health assets (RHA). After this, a protocol of a randomised clinical trial for analysing its effectiveness and cost-efficiency as a HA was developed. The participants will be assigned to: (1st) usual treatment by the primary care practitioner (TAU), as a control group; and (2nd) TAU + use of the APP as a HA and adjuvant treatment in their recovery + three motivational interviews (MI), as an interventional group. An evaluation will be carried out at baseline with further assessments three and six months following the end of the intervention. Discussion: Although research and care for these patients are still in their initial stages, it is necessary to equip patients and health care practitioners with tools to assist in their recovery. Furthermore, enhanced motivation can be achieved through telerehabilitation (TR). |
URI : | https://repositorio.usj.es/handle/123456789/1026 |
ISSN : | 1660-4601 |
Aparece en las colecciones: | Artículos de revistas |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed.pdf | 913,7 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons